Mice lacking ghrelin receptors resist the development of diet-induced obesity

Journal of Clinical Investigation

Volumn 115, Issue 12, 2005, Pages 3564-3572

  Zigman, Jeffrey M ^a   Nakano, Yoshihide ^a   Coppari, Roberto ^a   Balthasar, Nina ^a   Marcus, Jacob N ^a   Lee, Charlotte E ^a   Jones, Juli E ^a   Deysher, Amy E ^a   Waxman, Amanda R ^a   White, Ryan D ^a   Williams, Todd D ^a   Lachey, Jennifer L ^a   Seeley, Randy J ^b   Lowell, Bradford B ^a,c   Elmquist, Joel K ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; GROWTH HORMONE SECRETAGOGUE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; CALORIC INTAKE; CONTROLLED STUDY; DIET; FEMALE; FOOD DEPRIVATION; FOOD INTAKE; GLUCOSE BLOOD LEVEL; LIPID DIET; LOCOMOTION; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR INTRINSIC ACTIVITY; REGULATORY MECHANISM; SEX DIFFERENCE; SIGNAL TRANSDUCTION; WEIGHT CHANGE;

ADIPOSE TISSUE; ALLELES; ANALYSIS OF VARIANCE; ANIMAL FEED; ANIMALS; BLOOD GLUCOSE; BLOTTING, SOUTHERN; BLOTTING, WESTERN; BODY COMPOSITION; BODY WEIGHT; CROSSES, GENETIC; DIET; DNA; FEMALE; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HOMEOSTASIS; HYPERGLYCEMIA; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, INBRED C57BL; MODELS, GENETIC; NEURONS; OBESITY; PEPTIDE HORMONES; PHENOTYPE; RECEPTORS, G-PROTEIN-COUPLED; RECOMBINANT PROTEINS; RECOMBINATION, GENETIC; RNA, MESSENGER; SIGNAL TRANSDUCTION; SILVER STAINING; TIME FACTORS;

EID: 31044451759     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI26002     Document Type: Article

References (35)

1. Kojima, M., et al. 1999. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 402:656-660.
2. Cummings, D.E., et al. 2001. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 50:1714-1719.
3. Cummings, D.E., et al. 2002. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N. Engl. J. Med. 346:1623-1630.
4. Tschop, M., Smiley, D.L., and Heiman, M.L. 2000. Ghrelin induces adiposity in rodents. Nature. 407:908-913.
5. Nakazato, M., et al. 2001. A role for ghrelin in the central regulation of feeding. Nature. 409:194-198.
6. Asakawa, A., et al. 2001. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology. 120:337-345.
7. Kamegai, J., et al. 2000. Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology. 141:4797-4800.
8. Yasuda, T., Masaki, T., Kakuma, T., and Yoshimatsu, H. 2003. Centrally administered ghrelin suppresses sympathetic nerve activity in brown adipose tissue of rats. Neurosci. Lett. 349:75-78.
9. Asakawa, A., et al. 2003. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut. 52:947-952.
10. Tschop, M., Statnick, M.A., Suter, T.M., and Heiman, M.L. 2002. GH-releasing peptide-2 increases fat mass in mice lacking NPY: indication for a crucial mediating role of hypothalamic agouti-related protein. Endocrinology. 143:558-568.
11. Wren, A.M., et al. 2001. Ghrelin causes hyperphagia and obesity in rats. Diabetes. 50:2540-2547.
12. Sun, Y., Ahmed, S., and Smith, R.G. 2003. Deletion of ghrelin impairs neither growth nor appetite. Mol. Cell. Biol. 23:7973-7981.
13. Sun, Y., Wang, P., Zheng, H., and Smith, R.G. 2004. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc. Natl. Acad. Sci. U. S. A. 101:4679-4684.
14. Wortley, K.E., et al. 2004. Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc. Natl. Acad. Sci. U. S. A. 101:8227-8232.
15. Ashfield, R., et al. 1994. MAZ-dependent termination between closely spaced human complement genes. EMBO J. 13:5656-5667.
16. Joyner, A.L., Skarnes, W.C., and Rossant, J. 1989. Production of a mutation in mouse En-2 gene by homologous recombination in embryonic stem cells. Nature. 338:153-156.
17. Yonaha, M., and Proudfoot, N.J. 1999. Specific transcriptional pausing activates polyadenylation in a coupled in vitro system. Mol. Cell. 3:593-600.
18. Taicher, G.Z., Tinsley, F.C., Reiderman, A., and Heiman, M.L. 2003. Quantitative magnetic resonance (QMR) method for bone and whole-body-composition analysis. Anal. Bioanal. Chem. 377:990-1002.
19. Strader, A.D., Reizes, O., Woods, S.C., Benoit, S.C., and Seeley, R.J. 2004. Mice lacking the syndecan-3 gene are resistant to diet-induced obesity. J. Clin. Invest. 114:1354-1360. doi:10.1172/JCI200420631.
20. Chen, A.S., et al. 2000. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 26:97-102.
21. Picard, F., Deshaies, Y., Lalonde, J., Samson, P., and Richard, D. 2000. Topiramate reduces energy and fat gains in lean (Fa/?) and obese (fa/fa) Zucker rats. Obes. Res. 8:656-663.
22. Langley, S.C., and York, D.A. 1990. Effects of antiglucocorticoid RU 486 on development of obesity in obese fa/fa Zucker rats. Am. J. Physiol. 259:R539-R544.
23. Wortley, K.E., et al. 2005. Absence of ghrelin protects against early-onset obesity. J. Clin. Invest. 115:3573-3578. doi:10.1172/JCI26003.
24. Shuto, Y., et al. 2002. Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. J. Clin. Invest. 109:1429-1436. doi:10.1172/JCI200213300.
25. Tang-Christensen, M., et al. 2004. Central administration of ghrelin and agouti-related protein (83-132) increases food intake and decreases spontaneous locomotor activity in rats. Endocrinology. 145:4645-4652.
26. Holst, B., Cygankiewicz, A., Jensen, T.H., Ankersen, M., and Schwartz, T.W. 2003. High constitutive signaling of the ghrelin receptor - identification of a potent inverse agonist. Mol. Endocrinol. 17:2201-2210.
27. Jorgensen, J.O., et al. 1994. Adult growth hormone deficiency. Horm. Res. 42:235-241.
28. Dezaki, K., et al. 2004. Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in beta-cells: implication in the glycemic control in rodents. Diabetes. 53:3142-3151.
29. Broglio, F., et al. 2001. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J. Clin. Endocrinol. Metab. 86:5083-5086.
30. Muller, A.F., et al. 2001. Blockade of the growth hormone (GH) receptor unmasks rapid GH-releasing peptide-6-mediated tissue-specific insulin resistance. J. Clin. Endocrinol. Metab. 86:590-593.
31. Egido, E.M., Rodriguez-Gallardo, J., Silvestre, R.A., and Marco, J. 2002. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. Eur. J. Endocrinol. 146:241-244.
32. Muyrers, J.P., Zhang, Y., and Stewart, A.F. 2001. Techniques: recombinogenic engineering - new options for cloning and manipulating DNA. Trends Biochem. Sci. 26:325-331.
33. Lee, E.C., et al. 2001. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics. 73:56-65.
34. Marcus, J.N., et al. 2001. Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 435:6-25.
35. Kishi, T., et al. 2003. Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat. J. Comp. Neurol. 457:213-235.